Stories

Pharmacy benefit managers lobby against rebate rule

A Walgreens pharmacist fills an order.
A pharmacist fills a prescription. Photo: Jeffrey Greenberg / UIG via Getty Images

Lobbyists with the pharmacy benefit management industry met with federal officials last month, warning that Medicare Part D premiums will rise by 22% in 2019 if the government pursues an idea that would lower what Medicare patients pay for medications at the pharmacy counter.

Why it matters: PBMs and other companies that sell Medicare drug plans dislike the proposal, which would require them to apply rebates and fees at the point of sale as a way to make drugs cheaper, and a final ruling is expected soon.